各大洲的肝脏分配系统的变化,重点是MELD例外情况
Tomohiro Tanaka1, Abdul Rahman Hakeem2, Ryan Chadha3
1Division of Gastroenterology and Hepatology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.
概括
全球肝脏分配系统因地区而异,影响患者的治疗结果. 本综述比较了国际政策,包括MELD例外,以指导未来的器官分配策略.
科学领域:
- 肝病学和移植外科手术
- 公共卫生政策 公共卫生政策
- 器官捐赠和移植器官的使用
背景情况:
- 肝脏分配系统在全球不同,影响移植结果.
- 优化器官分配对于公平的患者护理至关重要.
- 需要国际合作来完善分配政策.
研究的目的:
- 提供肝脏分配系统的全球概述.
- 为了比较区域差异及其对结果的影响.
- 为未来的政策制定提供参考.
主要方法:
- 欧洲,亚洲,北美,南美和澳大利亚/加拿大的肝脏分配系统的审查.
- 对MELD例外情况进行比较,特别是对于肝细胞癌.
- 讨论活体捐赠和循环死亡后的捐赠实践.
主要成果:
- 在肝脏分配标准和MELD例外政策方面存在显著的区域差异.
- 肝细胞癌是全球MELD异常的主要驱动因素.
- 活体捐赠和DCD的采用率因地区而异.
结论:
- 了解国际变异是优化全球肝脏分配的关键.
- 协调政策,特别是对于MELD例外情况,可以改善移植公平.
- 这种比较分析是关于器官分配的国际对话的资源.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
180
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
180
Hepatic Portal System
5.3K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.3K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
211
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
211
Hepatic Drug Excretion: Influencing Factors
524
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
524


